Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged. The Health Services industry currently sits down 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 1.8%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.3%, CareFusion ( CFN), down 1.1%, Becton Dickinson ( BDX), down 0.9% and HCA Holdings ( HCA), down 0.9%. Top gainers within the industry include Select Medical Holdings Corporation ( SEM), up 4.3%, Globus Medical ( GMED), up 4.0% and DexCom ( DXCM), up 2.5%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $0.56 (-0.8%) to $67.92 on light volume. Thus far, 723,169 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $67.33-$68.30 after having opened the day at $68.30 as compared to the previous trading day's close of $68.48. St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $19.0 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 7 rate it a hold. TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.